Angiotensin converting enzyme insertion /deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome

被引:299
作者
Marshall, RP
Webb, S
Bellingan, GJ
Montgomery, HE
Chaudhari, B
McAnulty, RJ
Humphries, SE
Hill, MR
Laurent, GJ
机构
[1] UCL Royal Free & Univ Coll, London Med Sch, Rayne Inst, Ctr Resp Res, London WC1E 6JJ, England
[2] UCL Royal Free & Univ Coll, London Med Sch, Rayne Inst, Ctr Cardiovasc Genet, London WC1E 6JJ, England
关键词
acute respiratory distress syndrome; angiotensin converting enzyme; polymorphism (genetic);
D O I
10.1164/rccm.2108086
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acute respiratory distress syndrome (ARDS) is an often fatal condition for which a genetic predisposition is postulated, although no specific genes have been identified to date. Angiotensin converting enzyme (ACE) has a potential role in the pathogenesis of ARDS via effects on pulmonary vascular tone/permeability, epithelial cell survival, and fibroblast activation. Forty-seven percent of the variance in plasma ACE activity is accounted for by the ACE insertion/deletion (I/D) polymorphism, the D allele being associated with higher activity. We therefore hypothesized that the presence of the D allele would be associated with the development of ARDS. Ninety-six white patients fulfilling American/European Consensus Committee criteria for ARDS were genotyped for the ACE polymorphism together with individuals from three comparison groups: 88 white patients with non-ARDS respiratory failure ventilated in the intensive care unit (ICU), 174 ICU patients undergoing coronary artery bypass grafting, and 1,906 individuals from a general population group. DD genotype frequency was increased in the patients with ARDS compared with the ICU (p = 0.00008), coronary artery bypass grafting (p = 0.0009), and general population group (p = 0.00004) control groups and was significantly associated with mortality in the ARDS group (p < 0.02). These data suggest a potential role for renin-angiotensin systems in the pathogenesis of ARDS and for the first time implicate genetic factors in the development and progression of this syndrome.
引用
收藏
页码:646 / 650
页数:5
相关论文
共 41 条
[1]   High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma [J].
Benessiano, J ;
Crestani, B ;
Mestari, F ;
Klouche, W ;
Neukirch, F ;
HaceinBey, S ;
Durand, G ;
Aubier, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) :53-57
[2]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[3]   ANGIOTENSIN-II TYPE-1 RECEPTOR GENE POLYMORPHISMS IN HUMAN ESSENTIAL-HYPERTENSION [J].
BONNARDEAUX, A ;
DAVIES, E ;
JEUNEMAITRE, X ;
FERY, I ;
CHARRU, A ;
CLAUSER, E ;
TIRET, L ;
CAMBIEN, F ;
CORVOL, P ;
SOUBRIER, F .
HYPERTENSION, 1994, 24 (01) :63-69
[4]   IDENTIFICATION OF POLYMORPHIC SITES OF THE HUMAN BRADYKININ B-2 RECEPTOR GENE [J].
BRAUN, A ;
KAMMERER, S ;
BOHME, E ;
MULLER, B ;
ROSCHER, AA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (01) :234-240
[5]  
BRIZIOMOLTENI L, 1992, ANN CLIN LAB SCI, V22, P1
[6]  
CAMBIEN F, 1988, AM J HUM GENET, V43, P774
[7]   EFFECTS OF LOSARTAN ON ANGIOTENSIN AND BRADYKININ PEPTIDES AND ANGIOTENSIN-CONVERTING ENZYME [J].
CAMPBELL, DJ ;
KLADIS, A ;
VALENTIJN, AJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (02) :233-240
[8]   Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans [J].
Cargill, RI ;
Lipworth, BJ .
CHEST, 1996, 109 (02) :424-429
[9]   LINKAGE OF THE ANGIOTENSINOGEN GENE TO ESSENTIAL-HYPERTENSION [J].
CAULFIELD, M ;
LAVENDER, P ;
FARRALL, M ;
MUNROE, P ;
LAWSON, M ;
TURNER, P ;
CLARK, AJL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) :1629-1633
[10]   Early detection of type III procollagen peptide in acute lung injury - Pathogenetic and prognostic significance [J].
Chesnutt, AN ;
Matthay, MA ;
Tibayan, FA ;
Clark, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :840-845